Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 58: e20453, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1420370

ABSTRACT

Abstract Malaria is a disease caused by Plasmodium spp. protozoa. The ability of Plasmodium to develop resistance to current antimalarial drugs makes the study of chemotherapeutic alternatives extremely important. This study aimed to evaluate the antimalarial activity of compound 3286938 (1-(3-benzyloxy-4-methoxy-phenyl)-3-(3,4,5-trimethoxy-phenyl)-propan-1-one), which presents in its structure a 3,4,5-trimethoxyphenyl group, in vitro, using the W2 strain of P. falciparum and against circulating strains of P. vivax and P. falciparum from the state of Rondônia. The compound 3286938 obtained an IC50 of 24.4 µM against the W2 strain of P. falciparum, and against the circulating strains, it presented a median (MD)=38.7 µM for P. vivax and MD=6.7 µM for P. falciparum. As for toxicity, 3286938 showed CC50 > 500 µM for VERO and HepG2 strains with a selectivity index greater than 12.9, a ratio calculated for P. falciparum and P. vivax regarding Vero and HepG2 cells. The compound was not considered hemolytic in in vitro assays, thus indicating the specificity of its antiplasmodial action. Based on the results presented, and considering the unprecedented character of the compound, it can be concluded that 3286938 was shown to be promising for complementary in vitro and in vivo studies aiming to produce effective antiplasmodial action.

2.
Rev. Soc. Bras. Med. Trop ; 51(6): 849-853, Nov.-Dec. 2018. tab, graf
Article in English | LILACS | ID: biblio-1041494

ABSTRACT

Abstract INTRODUCTION Leishmaniasis, Chagas disease, and malaria cause morbidity globally. The drugs currently used for treatment have limitations. Activity of cinnamic acid analogs against Leishmania spp., Trypanosoma cruzi, and Plasmodium falciparum was evaluated in the interest of identifying new antiprotozoal compounds. METHODS In vitro effects of analogs against L. braziliensis, L. infantum chagasi, T. cruzi, and P. falciparum, and hemolytic and cytotoxic activities on NCTC 929 were determined. RESULTS Three analogs showed leishmanicidal and tripanocidal activity. No antiplasmodial, hemolytic, or cytotoxic activity was observed. CONCLUSIONS Antiprotozoal activity of analogs against L. infantum braziliensis, L. infantum chagasi, and T. cruzi was demonstrated.


Subject(s)
Plasmodium falciparum/drug effects , Trypanosoma cruzi/drug effects , Cinnamates/pharmacology , Leishmania/drug effects , Antiprotozoal Agents/pharmacology , Cinnamates/chemistry , Parasitic Sensitivity Tests , Antiprotozoal Agents/chemistry
3.
Rev. Soc. Bras. Med. Trop ; 51(3): 382-386, Apr.-June 2018. tab, graf
Article in English | LILACS | ID: biblio-1041466

ABSTRACT

Abstract INTRODUCTION This study assessed the activity of compounds from Piper tuberculatum against Plasmodium falciparum and Leishmania guyanensis. METHODS The effects of compounds from P. tuberculatum fruits on P. falciparum and L. guyanensis promastigote growth in vitro were determined. Hemolytic action and cytotoxicity in HepG2 and J774 cells were measured. RESULTS Three compounds showed strong antiplasmodial activity and one compound showed strong antileishmanial activity. Two compounds were non-toxic to HepG2 cells and all were toxic to J774 cells. The compounds showed no hemolytic activity. CONCLUSIONS The tested compounds from P. tuberculatum exhibited antiparasitic and cytotoxic effects.


Subject(s)
Humans , Plasmodium falciparum/drug effects , Plant Extracts/pharmacology , Leishmania guyanensis/drug effects , Piper/chemistry , Fruit/chemistry , Antiprotozoal Agents/pharmacology , Toxicity Tests , Inhibitory Concentration 50 , Hep G2 Cells/drug effects , Antiprotozoal Agents/isolation & purification
4.
Article in English | LILACS | ID: lil-758425

ABSTRACT

The preoccupation to find new drugs for the treatment of malaria is increasing steadily due to the resistance of the parasite, which is a threat to disease control, The present study describes a literature review on the antimalarial ethnopharmacology (Anti-Plasmodium falciparum - in vitro) of the Brazilian Amazon plants, It was found a great diversity of plant species in the Brazilian Amazon with potential for research of new herbal and secondary metabolites with antiplasmodial action, in addition to treating other neglected parasitic diseases, However, for these studies is needed in addition to financial support, the interaction between different laboratories and research groups for the formation of multidisciplinary and interdisciplinary teams, which will enhance the research level in the region and increase the likelihood of new antimalarial drugs discovery...


Está cada vez maior a necessidade em se buscar novos fármacos para o tratamento da malária, principalmente devido à resistência do parasito, o que é uma ameaça ao controle da doença. O presente estudo descreve uma revisão bibliográfica sobre a etnofarmacologia antimalárica (Anti-Plasmodium falciparum - in vitro) de plantas da Amazônia brasileira. Constatou-se uma grande diversidade de espécies vegetais na Amazônia brasileira com potencial para a investigação de novos fitoterápicos e metabólitos secundários com ação antiplasmodial, além do tratamento de outras parasitoses negligenciadas. Porém, para a realização desses estudos são necessários além de apoio financeiro, a interação entre diferentes laboratórios e grupos de pesquisa para a formação de equipes multidisciplinares e interdisciplinares, o que irá potencializar o nível da pesquisa na região e aumentar a probabilidade de descoberta de novos fármacos antimaláricos...


Subject(s)
Humans , Antimalarials/pharmacology , Ethnopharmacology/trends , Malaria, Falciparum/drug therapy , Brazil , Drug Resistance
SELECTION OF CITATIONS
SEARCH DETAIL